Mark W. Russo

6.4k total citations · 2 hit papers
101 papers, 4.3k citations indexed

About

Mark W. Russo is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Mark W. Russo has authored 101 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hepatology, 32 papers in Epidemiology and 28 papers in Surgery. Recurrent topics in Mark W. Russo's work include Liver Disease Diagnosis and Treatment (30 papers), Liver Disease and Transplantation (19 papers) and Hepatitis C virus research (19 papers). Mark W. Russo is often cited by papers focused on Liver Disease Diagnosis and Treatment (30 papers), Liver Disease and Transplantation (19 papers) and Hepatitis C virus research (19 papers). Mark W. Russo collaborates with scholars based in United States, Canada and United Kingdom. Mark W. Russo's co-authors include Michael Fried, Jeffrey Milbrandt, Nicholas J. Shaheen, Robert S. Sandler, Yehuda Ringel, Lisa M. Gangarosa, Roshan Shrestha, Michelle T. Thiny, Paul B. Watkins and Bradley R. Sevetson and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Mark W. Russo

95 papers receiving 4.2k citations

Hit Papers

The Burden of Gastrointestinal and Liver Diseases, 2006 2006 2026 2012 2019 2006 2023 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Burden of Gastrointestinal and Liver Diseases, 2006
    2006 516 citations Nicholas J. Shaheen, Richard A. Hansen et al. The American Journal of Gastroenterology profile →
  2. Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations
    2023 125 citations Éric Bouffet, Jordan R. Hansford et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark W. Russo United States 32 1.3k 1.0k 1.0k 815 679 101 4.3k
Hiromasa Ohira Japan 34 1.5k 1.2× 1.8k 1.7× 1.9k 1.9× 562 0.7× 931 1.4× 452 4.8k
Lei Shen China 34 1.2k 1.0× 372 0.4× 1.6k 1.6× 1.1k 1.4× 663 1.0× 119 6.4k
Laurent Spahr Switzerland 40 1.7k 1.4× 3.1k 3.0× 3.4k 3.3× 446 0.5× 453 0.7× 154 5.7k
Francesco Paolo Russo Italy 36 1.6k 1.3× 2.5k 2.4× 2.0k 1.9× 961 1.2× 792 1.2× 249 5.5k
K.E. Behrns United States 39 3.5k 2.8× 965 0.9× 1.2k 1.2× 878 1.1× 1.7k 2.4× 234 5.9k
Josep M. Piqué Spain 39 1.7k 1.3× 389 0.4× 761 0.7× 622 0.8× 824 1.2× 123 4.3k
Alan S. Rosman United States 29 771 0.6× 388 0.4× 836 0.8× 295 0.4× 669 1.0× 52 2.6k
Heinz Zoller Austria 44 620 0.5× 1.0k 1.0× 1.2k 1.2× 563 0.7× 485 0.7× 188 5.9k
Kazuhiro Hanazaki Japan 39 2.7k 2.2× 1.0k 1.0× 930 0.9× 881 1.1× 1.6k 2.3× 421 5.9k
Gary C. Kanel United States 36 831 0.7× 1.5k 1.5× 1.8k 1.8× 1.2k 1.5× 303 0.4× 95 4.5k

Countries citing papers authored by Mark W. Russo

Since Specialization
Citations

This map shows the geographic impact of Mark W. Russo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Russo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Russo more than expected).

Fields of papers citing papers by Mark W. Russo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark W. Russo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Russo. The network helps show where Mark W. Russo may publish in the future.

Co-authorship network of co-authors of Mark W. Russo

This figure shows the co-authorship network connecting the top 25 collaborators of Mark W. Russo. A scholar is included among the top collaborators of Mark W. Russo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark W. Russo. Mark W. Russo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bouffet, Éric, Jordan R. Hansford, Maria Luisa Garrè, et al.. (2023). Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations. New England Journal of Medicine. 389(12). 1108–1120. 125 indexed citations breakdown →
2.
3.
Hargrave, Darren, Éric Bouffet, Uri Tabori, et al.. (2019). Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation–Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study. Clinical Cancer Research. 25(24). 7303–7311. 125 indexed citations
4.
Kieran, Mark W., Birgit Geoerger, Ira J. Dunkel, et al.. (2019). A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory BRAF V600 Mutation–Positive Solid Tumors. Clinical Cancer Research. 25(24). 7294–7302. 58 indexed citations
5.
Rudnick, Sean & Mark W. Russo. (2017). Liver transplantation beyond or downstaging within the Milan criteria for hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology. 12(3). 265–275. 24 indexed citations
6.
Shah, Niraj James & Mark W. Russo. (2017). Is it time to rethink combined liver-kidney transplant in hepatitis C patients with advanced fibrosis?. World Journal of Hepatology. 9(5). 288–288. 1 indexed citations
7.
Kieran, Mark W., Éric Bouffet, Uri Tabori, et al.. (2016). CNS tumours The first study of dabrafenib in pediatric patients with BRAF V600–mutant relapsed or refractory low-grade gliomas. Annals of Oncology. 27. vi557–vi557. 13 indexed citations
8.
9.
10.
11.
Roila, Fausto, Janusz Rolski, Rodryg Ramlau, et al.. (2009). Randomized, double-blind, dose-ranging trial of the oral neurokinin-1 receptor antagonist casopitant mesylate for the prevention of cisplatin-induced nausea and vomiting. Annals of Oncology. 20(11). 1867–1873. 27 indexed citations
12.
Harrill, Alison H., Paul B. Watkins, Stephen Su, et al.. (2009). Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans. Genome Research. 19(9). 1507–1515. 136 indexed citations
13.
Russo, Mark W., et al.. (2008). Misperception among physicians and patients regarding the risks and benefits of statin treatment: the potential role of direct-to-consumer advertising. Journal of clinical lipidology. 2(1). 51–57. 20 indexed citations
14.
Bushel, Pierre R., Alexandra N. Heinloth, Lingkang Huang, et al.. (2007). Blood gene expression signatures predict exposure levels. Proceedings of the National Academy of Sciences. 104(46). 18211–18216. 90 indexed citations
15.
Evon, Donna M., Amit Verma, Mark W. Russo, et al.. (2007). High Deferral Rates and Poorer Treatment Outcomes for HCV Patients with Psychiatric and Substance Use Comorbidities. Digestive Diseases and Sciences. 52(11). 3251–3258. 38 indexed citations
16.
Shaheen, Nicholas J., Richard A. Hansen, Douglas R. Morgan, et al.. (2006). The Burden of Gastrointestinal and Liver Diseases, 2006. The American Journal of Gastroenterology. 101(9). 2128–2138. 516 indexed citations breakdown →
17.
Jacobson, Ira M., Furqaan Ahmed, Mark W. Russo, et al.. (2004). Interferon Alpha-2b and Ribavirin for Patients with Chronic Hepatitis C and Normal ALT. The American Journal of Gastroenterology. 99(9). 1700–1705. 24 indexed citations
18.
Russo, Mark W., et al.. (2004). Impact of Donor Age and Year of Transplant on Graft Survival in Liver Transplant Recipients with Chronic Hepatitis C. American Journal of Transplantation. 4(7). 1133–1138. 34 indexed citations
19.
Russo, Mark W.. (2002). Variceal bleeding. Current Treatment Options in Gastroenterology. 5(6). 471–477. 2 indexed citations
20.
Russo, Mark W., Sharon C. Murray, John I. Wurzelmann, John T. Woosley, & Robert S. Sandier. (1997). Plasma selenium levels and the risk of colorectal adenomas. Nutrition and Cancer. 28(2). 125–129. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiromasa Ohira Breakdown of academic impact, for papers by Lei Shen Breakdown of academic impact, for papers by Laurent Spahr Breakdown of academic impact, for papers by Francesco Paolo Russo Breakdown of academic impact, for papers by K.E. Behrns Breakdown of academic impact, for papers by Josep M. Piqué Breakdown of academic impact, for papers by Alan S. Rosman Breakdown of academic impact, for papers by Heinz Zoller Breakdown of academic impact, for papers by Kazuhiro Hanazaki Breakdown of academic impact, for papers by Gary C. Kanel
Rankless by CCL
2026